fluoxetine has been researched along with mifepristone in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Ang, W; Chang, Y; Chen, G; Deng, Y; Li, C; Liu, Y; Luo, Y; Pi, W; Wei, Y; Xiong, L; Yang, B; Yang, S; Zheng, J; Zhou, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dubuc, PU; Peterson, CM | 1 |
| Bethea, CL; Pecins-Thompson, M | 1 |
| Schatzberg, AF | 1 |
| Chen, NH; Li, J; Liu, Y; Sun, JD; Yuan, YH | 1 |
| Capuano, V; Ferron, L; Renaud, JF; Ruchon, Y; Sankhe, S | 1 |
| Baier, H; Ingraham, HA; Meijsing, SH; Muto, A; Schaaf, MJ; Schoonheim, PJ; Strasser, D; Yamamoto, KR; Ziv, L | 1 |
| Gao, Y; Li, Z; Liu, H; Wu, Y; Xu, Z; Zhang, C; Zhang, S | 1 |
| Chen, P; Fan, Y; Li, Y; Zhu, MY | 1 |
3 review(s) available for fluoxetine and mifepristone
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New approaches to managing psychotic depression.
Topics: Affective Disorders, Psychotic; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Drug Therapy, Combination; Electroconvulsive Therapy; Fluoxetine; Humans; Lithium; Mifepristone; Olanzapine; Pirenzepine; Receptors, Glucocorticoid; Treatment Outcome | 2003 |
12 other study(ies) available for fluoxetine and mifepristone
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis and biological evaluation of novel naphthalene compounds as potential antidepressant agents.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cell Line; Cell Survival; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Structure; Motor Activity; Naphthalenes; PC12 Cells; Rats; Structure-Activity Relationship; Swimming | 2014 |
Ineffectiveness of parenteral fluoxetine or RU-486 to alter long-term food intake, body weight or body composition of genetically obese mice.
Topics: Animals; Body Composition; Body Weight; Drug Administration Schedule; Eating; Female; Fluoxetine; Injections, Subcutaneous; Male; Mice; Mice, Obese; Mifepristone; Obesity; Parenteral Nutrition; Time Factors | 1990 |
RU 486 blocks and fluoxetine augments progesterone-induced prolactin secretion in monkeys.
Topics: Animals; Estradiol; Female; Fluoxetine; Hormone Antagonists; Kinetics; Macaca mulatta; Mifepristone; Progesterone; Prolactin; Receptors, Progesterone; Selective Serotonin Reuptake Inhibitors; Serotonin | 1997 |
Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats.
Topics: Analysis of Variance; Animals; Carbenoxolone; Connexin 43; Disease Models, Animal; Duloxetine Hydrochloride; Electroshock; Exploratory Behavior; Fluoxetine; Food Deprivation; Food Preferences; Gap Junctions; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hormone Antagonists; Inhibition, Psychological; Isoquinolines; Male; Microscopy, Electron, Transmission; Mifepristone; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Restraint, Physical; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Social Isolation; Stress, Psychological; Sucrose; Sweetening Agents; Swimming; Thiophenes | 2012 |
T-type Ca²⁺ signalling downregulates MEK1/2 phosphorylation and cross-talk with the RAAS transcriptional response in cardiac myocytes.
Topics: Animals; Calcium Signaling; Flunarizine; Fluoxetine; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mibefradil; Mifepristone; Mineralocorticoid Receptor Antagonists; Myocytes, Cardiac; Nifedipine; Phosphorylation; Rats; Rats, Wistar; Receptors, Glucocorticoid; Renin-Angiotensin System; Spironolactone | 2012 |
An affective disorder in zebrafish with mutation of the glucocorticoid receptor.
Topics: Analysis of Variance; Animals; Animals, Genetically Modified; Anti-Anxiety Agents; Arginine; Brain; Cell Line, Transformed; Chlorocebus aethiops; Corticotropin-Releasing Hormone; Cysteine; Diazepam; Disease Models, Animal; Escape Reaction; Exploratory Behavior; Fluoxetine; Freezing Reaction, Cataleptic; Hormone Antagonists; Humans; Hydrocortisone; Interpersonal Relations; Mifepristone; Mood Disorders; Mutation; Psychomotor Agitation; Radioimmunoassay; Receptors, Glucocorticoid; Serotonin; Transfection; Zebrafish | 2013 |
Bidirectional crosstalk between stress-induced gastric ulcer and depression under chronic stress.
Topics: Animals; Anti-Ulcer Agents; Corticosterone; Depression; Fluoxetine; Male; Mifepristone; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Stress, Psychological | 2012 |
Effects of chronic social defeat on expression of dopamine β-hydroxylase in rat brains.
Topics: Adrenalectomy; Animals; Antidepressive Agents; Brain; Desipramine; Dopamine beta-Hydroxylase; Fluoxetine; Hormone Antagonists; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Rats; Rats, Inbred F344; Rats, Long-Evans; RNA, Messenger; Social Behavior; Spironolactone; Stress, Psychological; Transcription, Genetic; Up-Regulation | 2013 |